NCT01460745View on ClinicalTrials.gov

A Retrospective Review of Liver Resection Rate in Metastatic Colorectal Cancer Patients Following Downsizing Treatment With Chemotherapy Plus Cetuximab in Normal UK National Health Service Clinical Practice

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions

Metastatic Colorectal Cancer

Trial Locations (5)

Unknown

Merck Serono Research Site, Bristol

Merck Serono Research Site, Liverpool

Merck Serono Research Site, London

Merck Serono Research Site, Manchester

Merck Serono Research Site, Southampton

All Listed Sponsors

collaborator

Merck Serono Limited, UK

INDUSTRY

lead

Merck KGaA, Darmstadt, Germany

INDUSTRY

NCT01460745 - A Retrospective Review of Liver Resection Rate in Metastatic Colorectal Cancer Patients Following Downsizing Treatment With Chemotherapy Plus Cetuximab in Normal UK National Health Service Clinical Practice | Biotech Hunter | Biotech Hunter